Citadel Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,674
| Closed | -$37.9K | – | 6703 |
|
|
2023
Q1 | $37.9K | Buy |
+4,674
| New | +$37.9K | ﹤0.01% | 5244 |
|
|
2022
Q4 | – | Sell |
-2,085
| Closed | -$29K | – | 6933 |
|
|
2022
Q3 | $29K | Buy |
+2,085
| New | +$29K | ﹤0.01% | 5460 |
|
|
2022
Q2 | – | Sell |
-686
| Closed | -$27K | – | 7181 |
|
|
2022
Q1 | $27K | Sell |
686
-5,326
| -89% | -$210K | ﹤0.01% | 6086 |
|
|
2021
Q4 | $254K | Buy |
6,012
+4,715
| +364% | +$199K | ﹤0.01% | 5271 |
|
|
2021
Q3 | $88K | Buy |
1,297
+978
| +307% | +$66.4K | ﹤0.01% | 5931 |
|
|
2021
Q2 | $25K | Sell |
319
-1,930
| -86% | -$151K | ﹤0.01% | 6311 |
|
|
2021
Q1 | $148K | Buy |
+2,249
| New | +$148K | ﹤0.01% | 5614 |
|
|
2020
Q2 | – | Sell |
-1,374
| Closed | -$34K | – | 5442 |
|
|
2020
Q1 | $34K | Buy |
+1,374
| New | +$34K | ﹤0.01% | 4593 |
|
|
2019
Q3 | – | Sell |
-297
| Closed | -$27K | – | 5250 |
|
|
2019
Q2 | $27K | Buy |
+297
| New | +$27K | ﹤0.01% | 4464 |
|
|
2019
Q1 | – | Sell |
-633
| Closed | -$100K | – | 5163 |
|
|
2018
Q4 | $100K | Sell |
633
-433
| -41% | -$68.4K | ﹤0.01% | 4003 |
|
|
2018
Q3 | $261K | Buy |
1,066
+608
| +133% | +$149K | ﹤0.01% | 3580 |
|
|
2018
Q2 | $103K | Sell |
458
-712
| -61% | -$160K | ﹤0.01% | 3824 |
|
|
2018
Q1 | $287K | Sell |
1,170
-76
| -6% | -$18.6K | ﹤0.01% | 3277 |
|
|
2017
Q4 | $384K | Buy |
1,246
+987
| +381% | +$304K | ﹤0.01% | 2993 |
|
|
2017
Q3 | $95K | Sell |
259
-479
| -65% | -$176K | ﹤0.01% | 3354 |
|
|
2017
Q2 | $269K | Buy |
+738
| New | +$269K | ﹤0.01% | 2986 |
|
|
2017
Q1 | – | Sell |
-146
| Closed | -$32K | – | 4291 |
|
|
2016
Q4 | $32K | Buy |
+146
| New | +$32K | ﹤0.01% | 3378 |
|